Adverse effects: addresses current clinical challenges with Orlistat-related gastrointestinal Orlistat, aimed at treating obesity, effectively aids in weight loss but is frequently linked to adverse gastrointestinal disorder reactions including oily stools, diarrhea, stomach pain, and fecal incontinence
Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection
L-
One common example is lead exposure
The oral formulation could provide a significant advantage over injectable alternatives, especially for patients who may have difficulty with injections or prefer non-injection-based treatments
we did not observe any obvious differences in the pre-treatment HbA1C between subjects taking sulfonylureas and thiazolidinediones and those who were not taking these medications Previous studies have reported that combining sulfonylureas or thiazolidinediones with GLP-1 M is an effective treatment for T2D [26,27,28,29]